Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 has been removed. This represents a minor update to the page's revision history metadata and does not indicate substantive changes.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new page revision tag Revision: v3.5.3 was added, and the previous tag Revision: v3.5.2 was removed. This reflects a minor update to the page's version history without modifying substantive content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.2 is now displayed on the page. The previous Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check37 days agoChange DetectedPadua, Italy, 35128 was replaced by Padova, Italy, 35128 in the Locations list (same postal code). This standardizes the site name to the local designation and improves accuracy in site identification for potential participants and staff.SummaryDifference0.0%

- Check45 days agoChange DetectedHb SS disease is listed as a related term; Genetic and Rare Diseases Information Center is added as a resource.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.